Differences in Liver Parenchyma are Measurable with CT Radiomics at Initial Colon Resection in Patients that Develop Hepatic Metastases from Stage II/III Colon Cancer.
John M CreasyKristen M CunananJayasree ChakrabortyJohn C McAuliffeJoanne ChouMithat GonenVictoria S KinghamMartin R WeiserVinod P BalachandranJeffrey A DrebinT Peter KinghamWilliam R JarnaginMichael I D'AngelicaRichard K G DoAmber L SimpsonPublished in: Annals of surgical oncology (2020)
CT radiomics is a promising tool to identify patients at high risk of developing liver metastases and is worthy of further investigation and validation.